Krystal Biotech, Inc. (KRYS)
346.79
+1.24
(+0.36%)
USD |
NASDAQ |
Sep 11, 16:00
346.79
0.00 (0.00%)
After-Hours: 16:25
Krystal Biotech Gross Profit (TTM) : 411.03M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 411.03M |
| March 31, 2026 | 386.93M |
| December 31, 2025 | 359.94M |
| September 30, 2025 | 345.59M |
| June 30, 2025 | 329.13M |
| March 31, 2025 | 304.08M |
| December 31, 2024 | 263.78M |
| September 30, 2024 | 216.94M |
| June 30, 2024 | 148.41M |
| March 31, 2024 | 84.92M |
| December 31, 2023 | 42.60M |
| September 30, 2023 | 3.744M |
| June 30, 2023 | -4.364M |
| March 31, 2023 | -4.14M |
| December 31, 2022 | -4.055M |
| September 30, 2022 | -3.75M |
| June 30, 2022 | -3.558M |
| March 31, 2022 | -3.247M |
| December 31, 2021 | -2.768M |
| September 30, 2021 | -2.474M |
| June 30, 2021 | -2.09M |
| Date | Value |
|---|---|
| March 31, 2021 | -1.819M |
| December 31, 2020 | -1.644M |
| September 30, 2020 | -1.43M |
| June 30, 2020 | -1.29M |
| March 31, 2020 | -1.136M |
| December 31, 2019 | -0.974M |
| September 30, 2019 | -0.759M |
| June 30, 2019 | -0.538M |
| March 31, 2019 | -0.321M |
| December 31, 2018 | -0.14M |
| September 30, 2018 | -0.093M |
| June 30, 2018 | -0.06M |
| March 31, 2018 | -0.04M |
| December 31, 2017 | -0.023M |
| September 30, 2017 | -0.01M |
| June 30, 2017 | -0.005M |
| March 31, 2017 | -0.003M |
| December 31, 2016 | -0.002M |
| September 30, 2016 | -0.001M |
| June 30, 2016 | -0.001M |
| March 31, 2016 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| TG Therapeutics, Inc. | 658.60M |
| Cytokinetics, Inc. | 46.98M |
| Marker Therapeutics, Inc. | 0.00 |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Exelixis, Inc. | 2.350B |